NHS could pay 25% more for medicines under plan to end row with drugmakers and Trump

<p>UK ministers preparing to raise payments to end standoff with pharma industry, cited as reason for firms axing British investments</p><p>Ministers are preparing to raise the amount the NHS pays pharmaceutical firms for medicines by up to 25% after weeks of intensive talks with the Donald Trump administration and drugmakers.</p><p>The government has drawn up fresh proposals to end a <a href="https://www.theguardian.com/commentisfree/2025/oct/01/big-pharma-war-uk-government-nhs-drugs">standoff with the industry over drug pricing</a>, including changing the cost-effectiveness thresholds under which new medications are assessed for use on the NHS, according to industry sources.</p> <a href="https://www.theguardian.com/business/2025/oct/08/nhs-could-pay-25-more-for-medicines-under-plan-to-end-row-with-drugmakers-and-trump">Continue reading...</a>